Literature DB >> 15655736

Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.

Denise S Matos1, Rilza B G Azeredo-Coutinho, Armando Schubach, Fátima Conceição-Silva, Cibele Baptista, João S Moreira, Sergio C F Mendonça.   

Abstract

BACKGROUND: Tegumentary leishmaniasis and leprosy display similar spectra of disease phenotypes, which are dependent on cell-mediated immunity to specific antigens. Diffuse cutaneous leishmaniasis and lepromatous leprosy represent the anergic end of the spectrum, whereas mucocutaneous leishmaniasis and tuberculoid leprosy are associated with marked antigen-specific cellular immune response.
METHODS: We characterized and compared the cell-mediated response to Leishmania and Mycobacterium leprae antigens in a patient with an intriguing association of mucocutaneous leishmaniasis with lepromatous leprosy, which are at opposite ends of the immunopathological spectra of these diseases. This was done by performance of skin tests and by assessment of the cell proliferation and cytokine production of peripheral blood mononuclear cells (PBMCs).
RESULTS: Strong skin-test reactions and PBMC proliferation were observed in response to Leishmania antigens but not to M. leprae antigens. The stimulation of PBMCs with Leishmania and M. leprae antigens induced comparable levels of tumor necrosis factor- alpha , interleukin-5, and interleukin-10. However, the interferon- gamma response to Leishmania antigens was remarkably high, and that to M. leprae antigens was almost nil.
CONCLUSIONS: We found that concomitant leprosy and tegumentary leishmaniasis can produce opposite polar forms associated, respectively, with absent or exaggerated cell-mediated immune responses to each pathogen. This suggests that independent mechanisms influence the clinical outcome of each infection. Moreover, interferon- gamma appears to play a major role in the clinical expression of these intracellular infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15655736     DOI: 10.1086/427069

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.

Authors:  E Telino; P M De Luca; D C S Matos; R B Azeredo-Coutinho; M N Meirelles; F Conceição-Silva; A Schubach; S C F Mendonça
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Divergent roles of IRAK4-mediated innate immune responses in two experimental models of severe malaria.

Authors:  Constance A M Finney; Ziyue Lu; Michael Hawkes; Wen-Chen Yeh; W Conrad Liles; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

3.  Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis.

Authors:  Mohammad H Alimohammadian; Stephen L Jones; Haideh Darabi; Farhad Riazirad; Soheila Ajdary; Aliakbar Shabani; Mohammad A Rezaee; Mehdi Mohebali; Zohreh Hosseini; Farrokh Modabber
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

4.  Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization.

Authors:  R B G Azeredo-Coutinho; D C S Matos; G G R Armôa; R M Maia; A Schubach; W Mayrink; S C F Mendonça
Journal:  Clin Exp Immunol       Date:  2008-07-08       Impact factor: 4.330

Review 5.  Tegumentary leishmaniasis and coinfections other than HIV.

Authors:  Dalila Y Martínez; Kristien Verdonck; Paul M Kaye; Vanessa Adaui; Katja Polman; Alejandro Llanos-Cuentas; Jean-Claude Dujardin; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2018-03-01

Review 6.  Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection.

Authors:  Jason D Simmons; Catherine M Stein; Chetan Seshadri; Monica Campo; Galit Alter; Sarah Fortune; Erwin Schurr; Robert S Wallis; Gavin Churchyard; Harriet Mayanja-Kizza; W Henry Boom; Thomas R Hawn
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 108.555

7.  Interleukin-10-dependent down-regulation of interferon-gamma response to Leishmania by Mycobacterium leprae antigens during the clinical course of a coinfection.

Authors:  R B G Azeredo-Coutinho; D C S Matos; J A C Nery; C M Valete-Rosalino; S C F Mendonça
Journal:  Braz J Med Biol Res       Date:  2012-05-10       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.